SM

Sriram Manas Mohapatra

Active Director Director DIN 10569964
DIN 10569964 First appointment Mar 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sriram Manas Mohapatra

Data last updated:

Sriram Manas Mohapatra is a Director at Coronary Pharmaceuticals Private Limited (since 2024). The company operates in Paper.

DIN 10569964
Primary Designation Director
Industry Paper
First Appointment 29 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20242024Active

Board colleagues of Sriram Manas Mohapatra

NameDINCompanyDesignation
Subhadra Mohapatra10569963Coronary Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Coronary Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sriram Manas Mohapatra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sriram Manas Mohapatra

Sriram Manas Mohapatra currently holds 1 directorship: Coronary Pharmaceuticals Private Limited (Director, since 29 Mar 2024).

Sriram Manas Mohapatra was first appointed on 29 Mar 2024 as Director at Coronary Pharmaceuticals Private Limited.

The current boards of Sriram Manas Mohapatra's companies include Subhadra Mohapatra (Coronary Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available